Browsing by Author Lett, Margaret

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2008p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumorsDunleavey, Ruth; Gallagher, Stuart; Gao, Bo-Fu; Indsto, James; Kefford, Richard (Rick); Mann, Graham; Rizos, Helen; Scurr, Lyndee; Thompson, John; Lett, Margaret; Western Clinical School (Westmead): Office; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Central Clinical School: Surgeryp16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors, NeoPlasia: an international journal of oncology research, vol.10, 11, 2008,pp 1231-1239
2004Phase I/II Study Of Treatment With Dendritic Cell Vaccines In Patients With Disseminated Melanoma.De Silva, Chitra; Halliday, Gary; Lett, Margaret; Menzies, Scott; Farrelly, Margaret L.; Hersey, Peter; Nguyen, Tam; Melanoma Foundation; Central Clinical School: Medicine; Melanoma Foundation; Central Clinical School: MedicinePhase I/II Study Of Treatment With Dendritic Cell Vaccines In Patients With Disseminated Melanoma., Cancer Immunology Immunotherapy, vol.53,(2),2004,pp 125-134
2008Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanomaHalliday, Gary; Menzies, Scott; DeSilva, C; Farrelly, Margaret L.; Hersey, Peter; Lett, Margaret; Central Clinical School: Medicine; Central Clinical School: MedicinePhase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma, Cancer Immunology Immunotherapy, vol.57,(7),2008,pp 1039-1051